Telmisartan 40mg + Chlorthalidone 12.5mg + Cilnidipine 10mg Tablet in PCD pharma franchise in Hyderabad

Telmisartan 40mg + Chlorthalidone 12.5mg + Cilnidipine 10mg Tablet in pharmaceutical manufacturing company in Mumbai

Telmisartan 40mg + Chlorthalidone 12.5mg + Cilnidipine 10mg Tablet in antihypertensive pharma franchise in Pune

Telmisartan 40mg + Chlorthalidone 12.5mg + Cilnidipine 10mg Tablet in pharma suppliers in Delhi

Telmisartan 40mg + Chlorthalidone 12.5mg + Cilnidipine 10mg Tablet in pharma export companies in Kolkata
Telmisartan 40mg + Chlorthalidone 12.5mg + Cilnidipine 10mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /telmisartan-ip-40mg-chlorthialidone-cilnidipine-10mg-tablets

Telbolife CLC 12.5 Tablet

Composition : Telmisartan IP 40mg + Chlorthialidone 12.5 + Cilnidipine 10mg Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Telbolife CLC 12.5 Tablet is a triple-combination antihypertensive formulation that includes Telmisartan 40mg (an angiotensin II receptor blocker), Chlorthalidone 12.5mg (a thiazide-like diuretic), and Cilnidipine 10mg (a calcium channel blocker). This synergistic combination targets high blood pressure through multiple mechanisms—relaxing blood vessels, reducing fluid retention, and improving blood flow—offering comprehensive and long-lasting blood pressure control.

Read More

About the Product

Telbolife CLC 12.5 Tablet is a triple-combination antihypertensive formulation that includes Telmisartan 40mg (an angiotensin II receptor blocker), Chlorthalidone 12.5mg (a thiazide-like diuretic), and Cilnidipine 10mg (a calcium channel blocker). This synergistic combination targets high blood pressure through multiple mechanisms—relaxing blood vessels, reducing fluid retention, and improving blood flow—offering comprehensive and long-lasting blood pressure control.

Common side effects may include dizziness, fatigue, increased urination, electrolyte imbalance, headache, and swelling of the feet or hands. Rarely, hypotension or kidney-related side effects may occur.

Indicated for the management of essential hypertension, especially in patients whose blood pressure is not adequately controlled with dual therapy.

Regular monitoring of blood pressure, kidney function, and electrolytes is essential. This medication should be taken as prescribed, preferably at the same time each day. Not recommended during pregnancy or breastfeeding without medical supervision.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation